Key Takeaways Expanded reimbursement and new codes are set to rapidly boost revenue, margins, and patient reach, accelerating growth ahead of earlier expectations. Strategic device offerings and operational models position the company for sustained growth, recurring revenue, and operating leverage in a growing dermatology market.Read more
Key Takeaways Expanded insurance coverage and new reimbursement codes are expected to greatly increase STRATA's eligible patient pool and revenue growth opportunities. Strong clinical evidence and physician-focused initiatives are driving deeper device adoption, supporting sustained growth and competitive advantage.Read more
Key Takeaways Heavy dependence on regulatory approvals, limited product range, and emerging treatment alternatives threaten revenue growth and recurring margin expansion. Shifting healthcare trends, high fixed costs, and international operational challenges pose significant risks to long-term profitability and business resilience.Read more
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, China, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. It operates through two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company offers XTRAC excimer laser and VTRAC lamp systems, which are used in the treatment of psoriasis, vitiligo, and other skin conditions; and TheraClear acne therapy system for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. It serves dermatologists and dermatological group clinics. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is headquartered in Horsham, Pennsylvania.
